vancomycin has been researched along with Dyslipidemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, JY; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, SH; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Peck, KR; Song, JH | 1 |
1 other study(ies) available for vancomycin and Dyslipidemia
| Article | Year |
|---|---|
Bacteremic meningitis caused by Parvimonas micra in an immunocompetent host.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria, Anaerobic; Ceftriaxone; Dyslipidemias; Firmicutes; Gram-Positive Bacterial Infections; Hepatitis B, Chronic; Humans; Male; Meningitis, Bacterial; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2015 |